Philip Vanek
Hoofd Techniek/Wetenschap/O&O bij Gamma Biosciences
Profiel
Philip G.
Vanek is associated with Centre For Commercialization of Regenerative Medicine and Gamma Biosciences.
He is currently working as the Director at Centre For Commercialization of Regenerative Medicine and as the Chief Technology Officer at Gamma Biosciences.
Actieve functies van Philip Vanek
Bedrijven | Functie | Begin |
---|---|---|
Centre For Commercialization of Regenerative Medicine
Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | Directeur/Bestuurslid | 16-07-2015 |
Gamma Biosciences
Gamma Biosciences Packaged SoftwareTechnology Services Gamma Biosciences operates as a life sciences tools platform. It focuses on next-generation bioprocessing and technologies for the production of advanced therapies, such as gene and cell-based therapies. The company was founded in 2019 and is headquartered in Menlo Park, CA. | Hoofd Techniek/Wetenschap/O&O | 01-04-2020 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Centre For Commercialization of Regenerative Medicine
Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | Health Technology |
Gamma Biosciences
Gamma Biosciences Packaged SoftwareTechnology Services Gamma Biosciences operates as a life sciences tools platform. It focuses on next-generation bioprocessing and technologies for the production of advanced therapies, such as gene and cell-based therapies. The company was founded in 2019 and is headquartered in Menlo Park, CA. | Technology Services |